Managing Tardive Dyskinesia: Clinical Pointers
Today's episode is about the management of tardive dyskinesia. Here are some questions we cover in this episode: What is the best way to approach tardive dyskinesia? This episode will discuss an algorithm with levels of evidence for each treatment option. What is the evidence level for second-generation VMAT-2 inhibitors, such as deutetrabenazine and valbenazine? Is there evidence for prescribing anticholinergics in tardive dyskinesia? Should you use them? What options do you have if a VMAT inhibitor is not effective or well tolerated? Faculty: Greg Pontone, M.D. Learn more about Premium Membership here Earn 1.25 CMEs: "Drug-Induced Movement Disorders: The Clinical Essentials" Treating Tardive Dyskinesia: A Clinical Conundrum and New Approaches
